阿司匹林联合氯吡格雷治疗急性脑梗死的临床效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (754 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the effect of Aspirin combined with Clopidogrel in the treatment of patients with acute cerebral infarction. Methods A total of 100 patients with acute cerebral infarction admitted to the Hongqi Hospital Affiliated to Mudanjiang Medical College from May 2019 to May 2020 were selected as the research objects, and they were divided into the reference group and the experimental group by drawing lots, with 50 cases in each group. The patients in the reference group received Aspirin. The experimental group was treated with Clopidogrel on the basis of the reference group. The therapeutic effect, the neurological function scores before and after treatment and the adverse reactions were compared between the two groups. Results The total effective rate of the experimental group was higher than that of the reference group, and the difference was statistically significant (P<0.05). Before treatment, there was no statistically significant difference in neurological function scores between the two groups (P>0.05). After 1, 5 and 10 d of treatment, the neurological function scores of the two groups were lower than those before treatment, and the differences were statistically significant (P<0.05). After 1, 5 and 10 d of treatment, the neurological function scores of the experimental group were lower than those of the reference group, and the differences were statistically significant (P<0.05). The total adverse reaction rate of the experimental group was lower than that of the reference group, and the difference was statistically significant (P<0.05). Conclusion The application of Aspirin combined with Clopidogrel in the treatment of acute cerebral infarction can improve the therapeutic effect and neurological function, and reduce the adverse reactions rate, which is worthy of clinical promotion and application.

Key words： Aspirin Clopidogrel Acute cerebral infarction Treatment effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GAO Yuqiu
	WANG Huiran
	ZHANG Kai▲

Cite this article:

GAO Yuqiu,WANG Huiran,ZHANG Kai▲. Clinical effect of Aspirin combined with Clopidogrel in the treatment of acute cerebral infarction[J]. 中国当代医药, 2022, 29(19): 129-131转135.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I19/129

[1]	陈博，杜岩.丁苯酞联合阿司匹林及氯吡格雷治疗急性脑梗死的疗效观察[J].沈阳医学院学报，2021，23（5）：451-453.
[2]	陈博，杜岩.阿司匹林联合氯吡格雷治疗急性脑梗死临床效果观察[J].临床军医杂志，2021，49（3）：352-353.
[3]	杨洪清，罗飏，马俊，等.阿司匹林与西洛他唑用于合并氯吡格雷抵抗老年急性脑梗死的二级预防效果比较[J].实用老年医学，2020，34（3）：270-273.
[4]	龙章玲，胡晓.阿司匹林和氯吡格雷在急性脑梗死中的应用进展[J].中国医药，2019，14（8）：1262-1265.
[5]	张磊，刘建民.美国国立卫生研究院卒中量表[J].中华神经外科杂志，2012（5）：455.
[6]	袁凤云，刘岩红.氯吡格雷联合拜阿司匹林治疗高龄急性脑梗死病人效果[J].蚌埠医学院学报，2019，44（6）：765-768.
[7]	高娟.阿司匹林联合氯吡格雷治疗急性脑梗死对患者认知功能的影响[J].解放军预防医学杂志，2018，36（9）：1204-1206，1219.
[8]	刘丽丹，田新玮，刘文萍，等.拜阿司匹林联合氯吡格雷在急性脑梗塞中的应用对CD-63、CD62P和PAC-1以及炎性因子、血小板聚集功能的影响[J].中国卫生检验杂志，2018，28（3）：332-334，337.
[9]	刘洋，姜盼盼，杨佳，等.阿司匹林联合氯吡格雷治疗急性脑梗死预后预测量表的建立及其效果的初步评价[J].中华神经医学杂志，2019（11）：1136-1141.
[10]	王挺刚，桂树华，狄美琪，等.阿司匹林、氯吡格雷联合疏血通注射液治疗急性脑梗死的临床效果及对血液流变学的影响[J].临床误诊误治，2019，32（1）：54-57.
[11]	章袁，朱立勤，徐彦贵，等.急性脑梗死患者不同抗血小板聚集治疗方案的疗效差异探讨[J].中国医药导刊，2019， 21（12）：744-748.
[12]	李杰文，周利胜，何显荣.氯吡格雷联合前列地尔在MCA致急性脑梗死病人中的应用效果及对血流动力学和预后的影响[J].中西医结合心脑血管病杂志，2019，17（10）：1560-1563.
[13]	李立，王骐，张娜，等.阿司匹林联合氯吡格雷治疗脑梗死的疗效及对氧化应激反应血液流变性的影响[J].河北医学，2018，24（11）：1922-1926.
[14]	芦璐，高阳，房淑欣.两种药物单独和联合使用对急性脑梗死患者血小板抑制率及超敏C反应蛋白水平的影响[J].检验医学与临床，2018，15（12）：1733-1736.
[15]	李爽，陈娟，刘科.阿托伐他汀联合氯吡格雷治疗对急性脑梗死患者炎症因子、凝血功能及血小板活化的影响研究[J].海南医学院学报，2018，24（7）：807-810.
[16]	陈冬良，林彬，林茵，等.阿司匹林联合硫酸氢氯吡格雷口服治疗脑梗死的临床效果分析[J].中国医药科学，2021，11（6）：178-181.
[17]	郭宏艳.阿司匹林+氯吡格雷治疗急性脑梗死的效果和安全性[J].中国当代医药，2021，28（4）：66-69.
[18]	冼文川，林力峰，林智君.拜阿司匹林联合氯吡格雷治疗急性轻型脑梗死的临床疗效及不良反应分析[J].中国医药科学，2020，10（1）：91-93.